Atlas Trials

Vaginal Estradiol Tablets (Vagifem®) and Endometrial Cancer Risk in the Treatment of Postmenopausal Vaginal Atrophy

Clinical trial NCT05243823 · COMPLETED

Trial details

NCT number
NCT05243823
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Study type
OBSERVATIONAL
Postmenopausal Vaginal Atrophy
Start date
2022-01-15
Primary completion
2022-07-31
Enrollment
500000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.